Biography

Steven Holtzman is the President and CEO of Decibel Therapeutics, a company devoted to discovering and developing therapeutics for hearing loss (2016-present). Previously he served as the Executive Vice President of Corporate Development at Biogen (2011-2016); the Founder, Chair, and CEO of Infinity Pharmaceuticals (2001-2010); the Chief Business Officer of Millennium Pharmaceuticals (1994-2001); and the Founder and President of DNX (1986-1994). He is a member of the Boards of Molecular Partners and the Berklee College of Music and a Senior Fellow at the Belfer Center for Science and International Affairs at Harvard Kennedy School. He was appointed by President Clinton and served as a member of the National Bioethics Commission (1996-2001) and served as a member and Vice Chair of the Board of the Hastings Center for the Life Sciences (1998-2009). He obtained his undergraduate degree in philosophy from Michigan State University and his graduate degree in philosophy from Oxford University which he attended as a Rhodes Scholar. He is a former Belfer Center non-resident senior fellow. 

 

Last Updated: Jan 27, 2020, 2:53pm

Awards

Contact